4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001349297-26-000004
Director sold 10,000 shares at $34.90 ($349,000)
- Director acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Fitzgerald Meghan · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-30 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,000 | $8.80 | $88,000 | 52,963 | D |
| 2026-06-30 | Sale : show line 2 in the form 10b5-1 | −10,000 | $34.90 | $349,000 | 42,963 | D |
| Open-market sales · 10,000 sh · avg $34.90 · $349,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-30 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −10,000 | 38,578 | D |
Loading xslF345X06/wk-form4_1783033435.xml…